In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases.

Due to the Memorial Day holiday (recognized on Monday, May 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the following plans for Domestic and International shipping:

Register now – July 8, 2025: PACE / State of FL - This webinar will discuss a range of critical topics essential for laboratory billing, coding, and compliance. Key areas of focus will include understanding and navigating National Correct Coding Initiative (NCCI) edits, reviewing newly released CPT codes, exploring important updates from Medicare Manuals, and discussing the process for submitting LCD Reconsideration Requests. Additionally, we will share insights into the latest priorities outlined in the OIG Workplan, helping organizations stay informed and aligned with federal expectations.

This month's microlearning explores effective strategies for managing emotions at work, including boosting self-awareness, regulating reactions, and fostering professional communication.

On this episode of Lab Medicine Rounds, Just Kreuter, M.D., chats with Jennifer Boland-Froemming, M.D., about creating the perfect rank list for training programs. Dr. Boland shares her insights and tips to help you make informed decisions.

Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends.

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Ellen Dijkman Dulkes and Brianne Newton. They discuss and share tips related to gathering customer input.

Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients

This month's episode of Lab Medicine Rounds, Justin Kreuter, M.D. speaks with Monica Ibarra, M.S., about the essential role of diversity, equity, and inclusion in healthcare and beyond.

PACE / State of FLThis webinar will discuss the advantages of using electrophysiology results to guide the selection of axonal or demyelinating testing for peripheral neuropathy. This approach can help identify specific antibodies associated with the condition, providing a more precise diagnosis, and improving patient outcomes. Accurate diagnosis is crucial for effective treatment, as the therapeutic approach varies based on the underlying cause of peripheral neuropathy.

Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.

Surveys are crucial for strengthening laboratory operations. Get insights for how to make them as effective as possible.

This microlearning will help learners develop the ability to include autoimmune movement disorders and related phenomena as part of the differential diagnosis, gain proficiency in categorizing autoimmune movement disorders based on phenotype and clinical progression, and identify effective strategies for diagnosing and managing autoimmune movement disorders.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss Dr. Morice’s recent article in Becker’s Hospital Review, “Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025.